Targeting the EGFR and immune pathways in squamous cell carcinoma of the head and neck (SCCHN): forging a new alliance

NF Saba, ZG Chen, M Haigentz, P Bossi… - Molecular cancer …, 2019 - AACR
Despite the recent approval of immune-modulatory agents, EGFR inhibition continues to be
a cornerstone in the management of squamous cell carcinoma of the head and neck …
被引用次数：28 相关文章

Targeting the EGFR and immune pathways in squamous cell carcinoma of the head and neck (SCCHN): Forging a new alliance

NF Saba, ZG Chen, M Haigentz, P Bossi… - MOLECULAR …, 2019 - iris.unibs.it
Despite the recent approval of immune-modulatory agents, EGFR inhibition continues to be
a cornerstone in the management of squamous cell carcinoma of the head and neck …

Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance.

NF Saba, ZG Chen, M Haigentz, P Bossi… - Molecular Cancer …, 2019 - europepmc.org
Despite the recent approval of immune-modulatory agents, EGFR inhibition continues to be
a cornerstone in the management of SCCHN namely in combination with radiotherapy in the …

[引用][C] Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance

NF Saba, ZG Chen, M Haigentz… - Molecular Cancer …, 2019 - researchportal.helsinki.fi
Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and
Neck (SCCHN): Forging a New Alliance — University of Helsinki Skip to main navigation Skip …

Targeting the EGFR and immune pathways in squamous cell carcinoma of the head and neck (SCCHN): Forging a new alliance

NF Saba, ZG Chen, M Haigentz, P Bossi… - MOLECULAR …, 2019 - iris.hunimed.eu
Despite the recent approval of immune-modulatory agents, EGFR inhibition continues to be
a cornerstone in the management of squamous cell carcinoma of the head and neck …

[引用][C] Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance

NF Saba, ZG Chen, M Haigentz, P Bossi, A Rinaldo… - 2019 - repository.ubn.ru.nl
Despite the recent approval of immune-modulatory agents, EGFR inhibition continues to be
a cornerstone in the management of squamous cell carcinoma of the head and neck …

[引用][C] Targeting the EGFR and immune pathways in squamous cell carcinoma of the head and neck (SCCHN): Forging a new alliance

NF Saba, ZG Chen, M Haigentz, P Bossi, A Rinaldo… - 2019 - ricerca.unityfvg.it

[引用][C] Targeting the EGFR and immune pathways in squamous cell carcinoma of the head and neck (SCCHN): Forging a new alliance

NF Saba, ZG Chen, M Haigentz, P Bossi… - MOLECULAR …, 2019 - air.uniud.it
Targeting the EGFR and immune pathways in squamous cell carcinoma of the head and
neck (SCCHN): Forging a new alliance IRIS IRIS Home Sfoglia Macrotipologie & tipologie …

Targeting the EGFR and immune pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): forging a new alliance

NF Saba, ZG Chen, M Haigentz… - Molecular cancer …, 2019 - repository.uantwerpen.be
Despite the recent approval of immune-modulatory agents, EGFR inhibition continues to be
a cornerstone in the management of squamous cell carcinoma of the head and neck …
[HTML] nih.gov

[HTML][HTML] Targeting the EGFR and immune pathways in squamous cell carcinoma of the head and neck (SCCHN): forging a new alliance

NF Saba, ZG Chen, M Haigentz, P Bossi… - Molecular cancer …, 2019 - ncbi.nlm.nih.gov
Despite the recent approval of immune-modulatory agents, EGFR inhibition continues to be
a cornerstone in the management of SCCHN namely in combination with radiotherapy in the …